Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Temple Wants US FDA To Consider Including PK/PD In Labels To Inform Dosing
Aug 14 2019
•
By
Michael Cipriano
Stakeholders discussed the best ways to improve precision dosing at an FDA public meeting.
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from R&D
More from Pink Sheet